0001367644-20-000004.txt : 20200117
0001367644-20-000004.hdr.sgml : 20200117
20200117161932
ACCESSION NUMBER: 0001367644-20-000004
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200116
FILED AS OF DATE: 20200117
DATE AS OF CHANGE: 20200117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Harsanyi Zsolt
CENTRAL INDEX KEY: 0001380184
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33137
FILM NUMBER: 20533801
MAIL ADDRESS:
STREET 1: 2273 RESEARCH BLVD., SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Emergent BioSolutions Inc.
CENTRAL INDEX KEY: 0001367644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 141902018
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
BUSINESS PHONE: 240-631-3200
MAIL ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
4
1
wf-form4_157929595097570.xml
FORM 4
X0306
4
2020-01-16
0
0001367644
Emergent BioSolutions Inc.
EBS
0001380184
Harsanyi Zsolt
400 PROFESSIONAL DR, SUITE 400
GAITHERSBURG
MD
20879
1
0
0
0
Common Stock
2020-01-16
4
S
0
3435
55
D
36273
D
Consists of restricted stock units granted the Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended.
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Harsanyi.
/s/ Scott Lieberman, Attorney-in-fact
2020-01-17